BIOL
Biolase, Inc.
BIOL
BIOL
Delisted
BIOL was delisted on the 18th of June, 2024.
26 hedge funds and large institutions have $1.42M invested in Biolase, Inc. in 2020 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
Holders
26
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$92K | |
| 2 | +$70.6K | |
| 3 | +$45.6K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$8K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$7.94K |
Top Sellers
| 1 | -$252K | |
| 2 | -$64.6K | |
| 3 | -$15.7K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$11K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$4.13K |